# US 2012/0232296 A1 · Antisolvent solidification process

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2012/0232296 A1
- Document ID: US20120232296A1
- Status: Published application
- Kind: A1
- Application number: 13/481,088
- Filed: 2012-05-25
- Published: 2012-09-13
- Earliest claimed: 2005-12-08
- Assignees: Organon USA, Inc.
- Inventors: Wridzer Jan Willem BAKKER; Robert Michael GEERTMAN; Marjanne Frederika REEDIJK; Jozef Johannes Maria BALTUSSEN; Gerrald BARGEMAN; Cornelis Elizabeth Johannus VAN LARE
- Web page: https://patentgrep.com/patent/US20120232296A1

## CPC

- B01D 9/0063: {Control or regulation (control per se G05)}
- A61K 9/14: Particulate form, e.g. powders, {Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles (microspheres A61K9/16; microcapsules A61K9/50; nanocapsules, nanoparticles of the matrix type A61K9/51)}
- A61K 9/1688: {resulting in pure drug agglomerate optionally containing up to 5% of excipient}
- A61K 31/57: substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61P 5/24: of the sex hormones
- A61P 5/38: of the suprarenal hormones
- B01D 9/005: {Selection of auxiliary, e.g. for control of crystallisation nuclei, of crystal growth, of adherence to walls; Arrangements for introduction thereof}
- B01D 9/0054: {Use of anti-solvent}
- C01D 3/24: Influencing the crystallisation process
- C07J 1/00: Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J 7/0005: {not substituted in position 21}
- C07J 7/0045: {not substituted in position 16}
- B01D: SEPARATION (separating solids from solids by wet methods B03B, B03D; by pneumatic jigs or tables B03B; by other dry methods B07; magnetic or electrostatic separation of solid materials from solid materials or fluids, separation by high-voltage electric fields B03C; centrifuges, vortex apparatus B04; presses per se for squeezing-out liquid from liquid-containing material B30B9/02; treatment of water C02F, e.g. softening by ion-exchange C02F1/42; {arrangements of air intake cleaners in gas turbine plants F02C7/05} ; arrangements or mounting of filters in air-conditioning, air-humidification or ventilation F24F13/28)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C01D: COMPOUNDS OF ALKALI METALS, i.e. LITHIUM, SODIUM, POTASSIUM, RUBIDIUM, CAESIUM, OR FRANCIUM (metal hydrides {monoborane, diborane or addition complexes thereof} C01B6/00; salts of oxyacids of halogens C01B11/00; peroxides, salts of peroxyacids C01B15/00; sulfides C01B17/22; thiosulfates, dithionites, polythionates C01B17/64; compounds containing selenium or tellurium C01B19/00; binary compounds of nitrogen with metals C01B21/06; azides C01B21/08; {compounds other than ammonia and cyanogen, containing nitrogen and other non-metals C01B21/082}; metal amides C01B21/092; nitrites C01B21/50; phosphides C01B21/50; {compounds of noble gases C01B23/0005}; phosphides C01B25/08; salts of oxyacids of phosphorus C01B25/16; carbides C01B32/90; compounds containing silicon C01B33/00; compounds containing boron C01B35/00; cyanides C01C3/08; salts of cyanic acid C01C3/14; salts of cyanamide C01C3/16; thiocyanates C01C3/20)
- C07J: STEROIDS (seco-steroids C07C)

## Abstract

The present invention relates to a antisolvent solidification process wherein a liquid medium comprising at least one organic or inorganic compound which is to be solidified is forced through a membrane into one or more antisolvents, or wherein one or more antisolvents are forced through a membrane into a liquid medium comprising at least one organic or inorganic compound which is to be solidified, yielding a composition comprising solid particles comprising said organic and/or inorganic compound(s).

## Claims

### Claim at position 1

20-31. (canceled)

### Claim 32 (depends on 20)

Crystalline particles obtainable by the process of claim 20 comprising at least one pharmaceutical compound which is preferably selected from the group consisting of tibolone, progesterone, desogestrel, and 3-keto-desogestrel (etonogestrel) showing only little and preferably essentially no agglomeration and having a span of the particle size distribution immediately after the crystallisation step of below 3.

### Claim 33 (depends on 32)

A pharmaceutical dosage form comprising crystalline particles according to claim 32.

### Claim 34 (depends on 32)

A pharmaceutical dosage form comprising crystalline particles according to claim 32 wherein the dosage form is a tablet.

### Claim 35 (depends on 32)

A method of using the crystalline particles according to claim 32 in the preparation of a pharmaceutical dosage form.

### Claim at position 6

36-38. (canceled)
